Article

When to consider corneal cross-linking treatment

Author(s):

Julianne Mobilian
Conferences|ASCRS

Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment 

Audrey Talley Rostov, MD, discusses corneal cross-linking (CXL) complications, and when to consider CXL treatment at the 2019 annual ASCRS meeting in San Diego.

RELATED: Intense pulsed light therapy for the treatment of chalazia

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
Related Content
GenEditBio doses first patient in investigator-initiated trial of GEB-101 for TGFBI corneal dystrophy
June 9th 2025

GenEditBio doses first patient in investigator-initiated trial of GEB-101 for TGFBI corneal dystrophy

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Ophthalmologists present data on perfluorohexylactane eye drops
June 6th 2025

Ophthalmologists present data on perfluorohexylactane eye drops

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

CCS 2025: Managing laser corneal refractive surgery and implantable collamer lens based procedures
June 1st 2025

CCS 2025: Managing laser corneal refractive surgery and implantable collamer lens based procedures

(Image credit: AdobeStock/frender) Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025
May 26th 2025

Q&A: Brandon D. Ayres, MD, on streamlining anterior vitrectomy with a high-speed, small-gauge probe at ASCRS 2025

© 2025 MJH Life Sciences

All rights reserved.